CSL Limited

Pharmaceuticals, Biotechnology and Life Sciences

Targets set1.5°C

SBTI ID

40012826

Informations générales

Localisation

Australia

Oceania

Secteur d'activité

Pharmaceuticals, Biotechnology and Life Sciences

Type d'organisation

Corporate

Dernière mise à jour

07/08/2025

Objectifs à court terme (Near-Term)
Engagement de réduction des émissions à horizon FY2030

Statut

Targets set

Classification

1.5°C

Année cible

FY2030

Progression vers l'objectif0%
2015 (année de référence)FY2030
Description complète des objectifs

Near-Term Targets: CSL Ltd. commits to reduce absolute scope 1 and 2 GHG emissions 42% by FY2030 from a FY2021 base year.* CSL Ltd. also commits that 73.1% of its suppliers by emissions covering purchased goods and services, capital goods, upstream transportation and distribution, business travel, and downstream transportation and distribution will have science-based targets by FY2030. *The target boundary includes land-related emissions and removals from bioenergy feedstocks.

Classification détaillée

The targets covering greenhouse gas emissions from company operations (scopes 1 and 2) are consistent with reductions required to keep warming to 1.5°C

Identifiants

ISIN

AU000000CSL8

Source : Science Based Targets initiative | Données publiques